Vascular and extravascular distribution of the ATP-binding cassette transporters ABCB1 and ABCC1 in aged human brain and pituitary

Mechanisms of Ageing and Development

Volumn 141, Issue , 2014, Pages 12-21

  Bernstein, Hans Gert ^a   Hölzl, Gloria ^a   Dobrowolny, Henrik ^a   Hildebrandt, Jens ^a   Trübner, Kurt ^b   Krohn, Markus ^a,c   Bogerts, Bernhard ^a   Pahnke, Jens ^a,c  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

ABC transporters; ATP binding cassette sub family B member 1 (ABCB1); ATP binding cassette sub family C member 1 (ABCC1); Blood brain barrier; Circumventricular organs; Human brain; Human pituitary; Neurons; Purinergic signalling

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE DEAMINASE; HYDROLASE; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 1; NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 2; UNCLASSIFIED DRUG; ABCB1 PROTEIN, HUMAN; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1; NERVE PROTEIN;

ADULT; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY ENDOTHELIAL CELL; BRAIN TISSUE; CELLULAR DISTRIBUTION; CHOROID PLEXUS; EPENDYMA CELL; EXTRAVASCULAR SPACE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHYSIS; HYPOPHYSIS CELL; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; IMMUNOLOCALIZATION; IMMUNOREACTIVITY; INTRACELLULAR SIGNALING; INTRAVASCULAR SPACE; MALE; NERVE CELL; NEUROMODULATION; PERICYTE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; AGING; BIOSYNTHESIS; GENE EXPRESSION REGULATION; METABOLISM; MIDDLE AGED; PHYSIOLOGY; VASCULARIZATION;

ADULT; AGING; BLOOD-BRAIN BARRIER; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NERVE TISSUE PROTEINS; P-GLYCOPROTEINS; PITUITARY GLAND;

EID: 84907529329     PISSN: 00476374     EISSN: 18726216     Source Type: Journal    
DOI: 10.1016/j.mad.2014.08.003     Document Type: Article

References (64)

1. Abbracchio M.P., et al. Purinergic signalling in the nervous system: an overview. Trends Neurosci. 2009, 32:19-29.
2. Ballerini P., et al. Glial cells express multiple ATP binding cassette proteins which are involved in ATP release. Neuroreport 2002, 13:1789-1792.
3. Bartels A.L., et al. Decreased blood-brain barrier P-glycoprotein function in the progression of Parkinson's disease, PSP and MSA. J. Neural Transm. 2008, 115:1001-1009.
4. Begley D.J. ABC transporters and the blood-brain barrier. Curr. Pharm. Des. 2004, 10:1295-1312.
5. Benarroch E.E. Circumventricular organs: receptive and homeostatic functions and clinical implications. Neurology 2011, 77:1198-1204.
6. Bendayan R., et al. Functional expression and localization of P-glycoprotein at the blood brain barrier. Microsc. Res. Tech. 2002, 57:365-380.
7. Bendayan R., et al. In situ localization of P-glycoprotein (ABCB1) in human and rat brain. J. Histochem. Cytochem. 2006, 54:1159-1167.
8. Bernstein H.G., et al. Regional and cellular distribution of neural visinin-like protein immunoreactivities (VILIP-1 and VILIP-3) in human brain. J. Neurocytol. 1999, 28:655-662.
9. Bernstein H.G., et al. ADAM (a disintegrin and metalloprotease) 12 is expressed in rat and human brain and localized to oligodendrocytes. J. Neurosci. Res. 2004, 75:353-360.
10. Bernstein H.G., et al. Regional and cellular distribution patterns of insulin-degrading enzyme in the adult human brain and pituitary. J. Chem. Neuroanat. 2008, 35:216-224.
11. Bernstein H.G., et al. Disruption of glutamate-glutamine-GABA cycle significantly impacts on suicidal behaviour: survey of the literature and own findings on glutamine synthetase. CNS Neurol. Disord. Drug Targets 2013, 12:900-913.
12. Bernstein H.G., et al. Cytochemical investigations on the localization of 5'-nucleotidase in the rat hippocampus with special reference to synaptic regions. Histochemistry 1978, 55:261-267.
13. Burnstock G. Physiology and pathophysiology of purinergic neurotransmission. Physiol. Rev. 2007, 87:659-797.
14. Burnstock G. Introduction to purinergic signalling in the brain. Adv. Exp. Med. Biol. 2013, 986:1-12.
15. Burnstock G., et al. Purinergic signalling: from normal behaviour to pathological brain function. Prog. Neurobiol. 2011, 95:229-274.
16. Cirrito J.R., et al. P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. J. Clin. Invest. 2005, 115:3285-3290.
17. Cordon-Cardo C., et al. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc. Natl. Acad. Sci. USA 1989, 86:695-698.
18. Daood M., et al. ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS. Neuropediatrics 2008, 39:211-218.
19. Diaz-Rubio E., et al. The antiemetic efficacy of thiethylperazine and methylprednisolone versus thiethylperazine and placebo in breast cancer patients treated with adjuvant chemotherapy (fluorouracil, doxorubicin and cyclophosphamide). A randomized, double-blind, cross-over trial. Acta Oncol. 1991, 30:339-342.
20. Enokido M., et al. Implication of P-Glycoprotein in Formation of Depression-Prone Personality: Association Study between the C3435T MDR1 Gene Polymorphism and Interpersonal Sensitivity. Neuropsychobiology 2014, 69:89-94.
21. Gampe K., et al. The medial habenula contains a specific nonstellate subtype of astrocyte expressing the ectonucleotidase NTPDase2. Glia 2012, 60:1860-1870.
22. Ganong W.F. Circumventricular organs: definition and role in the regulation of endocrine and autonomic function. Clin. Exp. Pharmacol. Physiol. 2000, 27:422-427.
23. Gazzin S., et al. Differential expression of the multidrug resistance-related proteins ABCb1 and ABCc1 between blood-brain interfaces. J. Comp. Neurol. 2008, 510:497-507.
24. Gosselet F., et al. Amyloid-beta peptides, Alzheimer's disease and the blood-brain barrier. Curr. Alzheimer Res. 2013, 10:1015-1033.
25. Hartz A.M., Bauer B. Regulation of ABC transporters at the blood-brain barrier: new targets for CNS therapy. Mol. Interv. 2010, 10:293-304.
26. Hunter J.M., et al. Morphological and pathological evolution of the brain microcirculation in aging and Alzheimer's disease. PLoS One 2012, 7:e36893.
27. Keep R.F., Smith D.E. Choroid plexus transport: gene deletion studies. Fluids Barriers CNS 2011, 8:26.
28. Kim W.S., et al. Deletion of Abca7 increases cerebral amyloid-beta accumulation in the J20 mouse model of Alzheimer's disease. J. Neurosci. 2013, 33:4387-4394.
29. Koldamova R., et al. The role of ATP-binding cassette transporter A1 in Alzheimer's disease and neurodegeneration. Biochim. Biophys. Acta 2010, 1801:824-830.
30. Krohn M., et al. Cerebral amyloid-beta proteostasis is regulated by the membrane transport protein ABCC1 in mice. J. Clin. Invest. 2011, 121:3924-3931.
31. Kulesskaya N., et al. CD73 is a major regulator of adenosinergic signalling in mouse brain. PLoS One 2013, 8:e66896.
32. Lee G., Bendayan R. Functional expression and localization of P-glycoprotein in the central nervous system: relevance to the pathogenesis and treatment of neurological disorders. Pharm. Res. 2004, 21:1313-1330.
33. Lee Y.J., et al. Do multidrug resistance-associated protein-1 and -2 play any role in the elimination of estradiol-17 beta-glucuronide and 2,4-dinitrophenyl-S-glutathione across the blood-cerebrospinal fluid barrier?. J. Pharm. Sci. 2004, 93:99-107.
34. Li Y., et al. Novel and functional ABCB1 gene variant in sporadic Parkinson's disease. Neurosci. Lett. 2014, 566:61-66.
35. Martin-Jimenez M., et al. Antiemetic combination for PAC (cisplatin-adriamycin-cyclophosphamide) chemotherapy-induced emesis in ovarian cancer. Eur. J. Gynaecol. Oncol. 1987, 8:98-102.
36. Martin Jimenez M., Diaz-Rubio E. Antiemetic combination for cisplatin-induced emesis. Results from a controlled study. Bull. Cancer. 1986, 73:294-298.
37. Mitsuishi H., et al. Characterization of a pituitary-tumor-derived cell line, TtT/GF, that expresses Hoechst efflux ABC transporter subfamily G2 and stem cell antigen 1. Cell Tissue Res. 2013, 354:563-572.
38. Muller M.B., et al. ABCB1 (MDR1)-type P-glycoproteins at the blood-brain barrier modulate the activity of the hypothalamic-pituitary-adrenocortical system: implications for affective disorder. Neuropsychopharmacology 2003, 28:1991-1999.
39. Mutafova-Yambolieva V.N., Durnin L. The purinergic neurotransmitter revisited: A single substance or multiple players?. Pharmacol. Ther. 2014, pii:S0163-7258(14)00107-7, [Epub ahead of print], PMID: 24887688. 10.1016/j.pharmthera.2014.05.012.
40. Nies A.T., et al. Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain. Neuroscience 2004, 129:349-360.
41. Pahnke J., et al. Impaired mitochondrial energy production and ABC transporter function-A crucial interconnection in dementing proteopathies of the brain. Mech. Ageing Dev. 2013, 134:506-515.
42. Pahnke J., et al. Alzheimer's disease and blood-brain barrier function-why have anti-beta-amyloid therapies failed to prevent dementia progression?. Neurosci. Biobehav. Rev. 2009, 33:1099-1108.
43. Pahnke J., et al. Clinico-pathologic function of cerebral ABC transporters - implications for the pathogenesis of Alzheimer's disease. Curr. Alzheimer Res. 2008, 5:396-405.
44. Piontkewitz Y., et al. Effects of risperidone treatment in adolescence on hippocampal neurogenesis, parvalbumin expression, and vascularization following prenatal immune activation in rats. Brain Behav. Immun. 2012, 26:353-363.
45. Radi A. Torecan, a review of references and clinical control examinations. Ther. Hung. 1990, 38:56-59.
46. Roberts L.M., et al. Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in vivo biotinylation. Neuroscience 2008, 155:423-438.
47. Santos M., et al. Common genetic polymorphisms in the ABCB1 gene are associated with risk of major depressive disorder in male Portuguese individuals. Genet. Test Mol. Biomarkers 2014, 18:12-19.
48. Scheffler K., et al. Mitochondrial DNA polymorphisms specifically modify cerebral beta-amyloid proteostasis. Acta Neuropathol. 2012, 124:199-208.
49. Schinkel A.H. Pharmacological insights from P-glycoprotein knockout mice. Int. J. Clin. Pharmacol. Ther. 1998, 36:9-13.
50. Schinkel A.H., Jonker J.W. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv. Drug Deliv. Rev. 2003, 55:3-29.
51. Schumacher T., et al. ABC transporters B1, C1 and G2 differentially regulate neuroregeneration in mice. PLoS One 2012, 7:e35613.
52. Soontornmalai A., et al. Differential, strain-specific cellular and subcellular distribution of multidrug transporters in murine choroid plexus and blood-brain barrier. Neuroscience 2006, 138:159-169.
53. Staines W.A., et al. Distribution, morphology and habenular projections of adenosine deaminase-containing neurons in the septal area of rat. Brain Res. 1988, 455:72-87.
54. Takahashi K., et al. ABC proteins: key molecules for lipid homeostasis. Med. Mol. Morphol. 2005, 38:2-12.
55. Thiebaut F., et al. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc. Natl. Acad. Sci. USA 1987, 84:7735-7738.
56. van Assema D.M., et al. Blood-brain barrier P-glycoprotein function in Alzheimer's disease. Brain 2012, 135:181-189.
57. Vogelgesang S., et al. Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans. Pharmacogenetics 2002, 12:535-541.
58. Vogelgesang S., et al. The role of P-glycoprotein in cerebral amyloid angiopathy; implications for the early pathogenesis of Alzheimer's disease. Curr. Alzheimer Res. 2004, 1:121-125.
59. Warren M.S., et al. Comparative gene expression profiles of ABC transporters in brain microvessel endothelial cells and brain in five species including human. Pharmacol. Res. 2009, 59:404-413.
60. Willis C.L., et al. Microvascular P-glycoprotein expression at the blood-brain barrier following focal astrocyte loss and at the fenestrated vasculature of the area postrema. Brain Res. 2007, 1173:126-136.
61. Wolf A., et al. ABC transporters and the Alzheimer's disease enigma. Front. Psychiatry 2012, 3:54.
62. Yamagishi T., et al. P-glycoprotein mediates drug resistance via a novel mechanism involving lysosomal sequestration. J. Biol. Chem. 2013, 288:31761-31771.
63. Yamamoto T., et al. Subcellular, regional and immunohistochemical localization of adenosine deaminase in various species. Brain Res. Bull. 1987, 19:473-484.
64. Yu N., et al. Nuclear factor-kappa B activity regulates brain expression of P-glycoprotein in the kainic acid-induced seizure rats. Mediators Inflamm. 2011, 2011:670613.